Genetic Engineering and Biotechnolgy News is one of the leading journals in biotechnology, showcasing groundbreaking technologies and the latest advanced in the biotech field. Check out the latest article published at the prestigious journal and [...]
Microviable Therapeutics will be at The Microbiome Times Partnering Forum taking place in Brussels on March 18-19th 2025. Claudio Hidalgo, PhD., cofounder and CEO, and David Ríos Covián, PhD., CTO will be attending The Microbiome [...]
Pilar Manrique, senior scientist at Microviable Therapeutics will be present at 9th Microbiome Microbiome Movement Summit taking place in Barcelona in January 28-30th 2025! The Summit explored the latest advances in microbiome science, where innovative [...]
David Ríos Covián, Director of Technology Development at Microviable Therapeutics, will participate in the 24th Drug Discovery Innovation Programme that will take place on 19-20 September in Barcelona. Particularly, David Rios will be present as [...]
Microviable is excited to join 24th Drug Discovery Innovation Programme that will take place on 19-20 September in Barcelona. Claudio Hidalgo, CEO at Microviable, will participate as a speaker at the event. Drug Discovery Innovation [...]
The work, led by a joint IPLA-University of Oviedo research group and the company Microviable Therapeutics, with Susana Delgado, from IPLA-CSIC, as the responsible researcher, has managed to identify and select bacteria in the microbiota [...]
Claudio Hidalgo Cantabrana, CEO at Microviable Therapeutics, and our CBO, Rafael Permuy, will be attending Bio€quity Europe event in San Sebastián (Spain) from May 12th to 14th and May 21, 22 (virtual). On Tuesday 14th [...]
Microviable Therapeutics has signed a collaboration agreement with the Healthcare & Lifescience division of Deltalab (member of SCGP) for the international distribution of GutAlive® kit for the collection and transport of microbiota. Thanks to [...]
Claudio Hidalgo Cantabrana, CEO at Microviable Therapeutics, and our CBO, Rafael Permuy, will be attending Bio€quity Europe event in San Sebastián (Spain) from May 12th to 14th and May 21, 22 (virtual). Microviable Team joins [...]
Microviable Therapeutics will participate in Microbiome Connect USA that will take place from November 14th to 16th in Boston. Claudio Hidalgo Cantabrana, CEO at Microviable, will join a like-minded community of 300 scientists and entrepreneurs [...]